Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Face | 4 | 2021 | 19 | 2.290 |
Why?
|
| Surgery, Plastic | 3 | 2020 | 8 | 2.050 |
Why?
|
| Nose | 2 | 2020 | 27 | 1.360 |
Why?
|
| Quality of Life | 2 | 2021 | 600 | 1.020 |
Why?
|
| Laryngostenosis | 2 | 2023 | 5 | 0.950 |
Why?
|
| Esthetics | 2 | 2020 | 12 | 0.870 |
Why?
|
| Photography | 2 | 2020 | 13 | 0.850 |
Why?
|
| Skin | 2 | 2020 | 99 | 0.820 |
Why?
|
| Narcotics | 2 | 2020 | 35 | 0.810 |
Why?
|
| Analgesia | 2 | 2020 | 34 | 0.810 |
Why?
|
| Facial Paralysis | 2 | 2021 | 9 | 0.800 |
Why?
|
| Information Seeking Behavior | 1 | 2021 | 3 | 0.770 |
Why?
|
| Search Engine | 1 | 2021 | 6 | 0.770 |
Why?
|
| Internet | 2 | 2022 | 93 | 0.760 |
Why?
|
| Head and Neck Neoplasms | 2 | 2020 | 146 | 0.740 |
Why?
|
| Voice | 1 | 2021 | 5 | 0.740 |
Why?
|
| Spirometry | 1 | 2021 | 11 | 0.740 |
Why?
|
| Beauty | 1 | 2020 | 2 | 0.710 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2020 | 2 | 0.710 |
Why?
|
| Cephalometry | 1 | 2020 | 4 | 0.710 |
Why?
|
| Forehead | 1 | 2020 | 2 | 0.690 |
Why?
|
| Patients | 1 | 2020 | 32 | 0.690 |
Why?
|
| Patient Preference | 1 | 2020 | 28 | 0.690 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2021 | 450 | 0.680 |
Why?
|
| Free Tissue Flaps | 1 | 2019 | 13 | 0.660 |
Why?
|
| Anesthesia | 1 | 2019 | 27 | 0.660 |
Why?
|
| Sex Characteristics | 1 | 2020 | 94 | 0.660 |
Why?
|
| Biomedical Research | 1 | 2020 | 57 | 0.650 |
Why?
|
| Pain, Postoperative | 2 | 2020 | 293 | 0.650 |
Why?
|
| Social Media | 1 | 2020 | 45 | 0.650 |
Why?
|
| Health Behavior | 1 | 2020 | 136 | 0.640 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2019 | 54 | 0.640 |
Why?
|
| Endoscopy | 2 | 2019 | 168 | 0.630 |
Why?
|
| Evidence-Based Medicine | 1 | 2020 | 170 | 0.630 |
Why?
|
| Facial Nerve Diseases | 1 | 2018 | 3 | 0.630 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2018 | 4 | 0.630 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2018 | 4 | 0.630 |
Why?
|
| Humans | 27 | 2023 | 25692 | 0.600 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 154 | 0.560 |
Why?
|
| Sleep | 1 | 2019 | 316 | 0.540 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 698 | 0.520 |
Why?
|
| Female | 17 | 2022 | 14273 | 0.470 |
Why?
|
| Rhinitis | 3 | 2021 | 131 | 0.450 |
Why?
|
| Sinusitis | 3 | 2021 | 144 | 0.440 |
Why?
|
| Male | 14 | 2021 | 13917 | 0.400 |
Why?
|
| Rhinoplasty | 2 | 2022 | 11 | 0.370 |
Why?
|
| Otolaryngology | 2 | 2021 | 18 | 0.360 |
Why?
|
| Middle Aged | 11 | 2021 | 8403 | 0.350 |
Why?
|
| Drug Utilization | 2 | 2020 | 20 | 0.340 |
Why?
|
| Retrospective Studies | 9 | 2020 | 3220 | 0.340 |
Why?
|
| Neoplasm Staging | 3 | 2020 | 315 | 0.330 |
Why?
|
| SEER Program | 2 | 2019 | 37 | 0.310 |
Why?
|
| Nose Neoplasms | 2 | 2019 | 40 | 0.300 |
Why?
|
| Paranasal Sinus Neoplasms | 2 | 2019 | 58 | 0.300 |
Why?
|
| Aged | 8 | 2021 | 8501 | 0.290 |
Why?
|
| Adult | 6 | 2021 | 7336 | 0.280 |
Why?
|
| Survival Rate | 4 | 2020 | 308 | 0.260 |
Why?
|
| Head | 2 | 2022 | 22 | 0.210 |
Why?
|
| Nasal Cartilages | 1 | 2022 | 3 | 0.200 |
Why?
|
| Education, Distance | 1 | 2022 | 18 | 0.190 |
Why?
|
| Mandibular Nerve | 1 | 2021 | 5 | 0.180 |
Why?
|
| Hypoglossal Nerve | 1 | 2021 | 5 | 0.180 |
Why?
|
| Prospective Studies | 3 | 2021 | 1633 | 0.180 |
Why?
|
| Speech | 1 | 2021 | 22 | 0.180 |
Why?
|
| Nerve Transfer | 1 | 2021 | 5 | 0.180 |
Why?
|
| Professional Role | 1 | 2021 | 30 | 0.180 |
Why?
|
| Dyspnea | 1 | 2021 | 37 | 0.180 |
Why?
|
| Pain Measurement | 2 | 2020 | 415 | 0.180 |
Why?
|
| Glottis | 1 | 2020 | 4 | 0.180 |
Why?
|
| Prescriptions | 1 | 2020 | 18 | 0.170 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2020 | 1 | 0.170 |
Why?
|
| Cohort Studies | 3 | 2020 | 1781 | 0.170 |
Why?
|
| Biometry | 1 | 2020 | 6 | 0.170 |
Why?
|
| Feminization | 1 | 2020 | 2 | 0.170 |
Why?
|
| Tracheostomy | 1 | 2020 | 23 | 0.170 |
Why?
|
| Laryngeal Neoplasms | 1 | 2020 | 28 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 70 | 0.170 |
Why?
|
| Physician-Patient Relations | 1 | 2020 | 37 | 0.170 |
Why?
|
| Lymphatic Metastasis | 1 | 2020 | 81 | 0.170 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 847 | 0.170 |
Why?
|
| Rural Population | 1 | 2020 | 23 | 0.170 |
Why?
|
| Epiglottis | 1 | 2019 | 1 | 0.170 |
Why?
|
| Tongue | 1 | 2019 | 10 | 0.170 |
Why?
|
| Surgeons | 1 | 2021 | 86 | 0.170 |
Why?
|
| Motivation | 1 | 2020 | 89 | 0.170 |
Why?
|
| Patient Care Planning | 1 | 2020 | 45 | 0.170 |
Why?
|
| Treatment Outcome | 4 | 2021 | 3231 | 0.170 |
Why?
|
| Simulation Training | 1 | 2020 | 35 | 0.170 |
Why?
|
| Eosinophilia | 1 | 2019 | 35 | 0.170 |
Why?
|
| Robotic Surgical Procedures | 1 | 2020 | 34 | 0.170 |
Why?
|
| Eosinophils | 1 | 2019 | 44 | 0.160 |
Why?
|
| Neck | 1 | 2019 | 23 | 0.160 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 124 | 0.160 |
Why?
|
| Betacoronavirus | 1 | 2020 | 65 | 0.160 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 74 | 0.160 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 98 | 0.160 |
Why?
|
| Lymphoma, Extranodal NK-T-Cell | 1 | 2019 | 4 | 0.160 |
Why?
|
| Urban Population | 1 | 2020 | 149 | 0.160 |
Why?
|
| Morphine | 1 | 2019 | 60 | 0.160 |
Why?
|
| Insurance Coverage | 1 | 2019 | 15 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 77 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 80 | 0.150 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2018 | 32 | 0.150 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 132 | 0.150 |
Why?
|
| Clinical Competence | 1 | 2020 | 217 | 0.150 |
Why?
|
| Internship and Residency | 1 | 2021 | 196 | 0.150 |
Why?
|
| Registries | 1 | 2018 | 170 | 0.150 |
Why?
|
| Length of Stay | 1 | 2019 | 300 | 0.140 |
Why?
|
| Patient Satisfaction | 1 | 2020 | 284 | 0.140 |
Why?
|
| Analgesics, Opioid | 1 | 2019 | 209 | 0.130 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 1077 | 0.130 |
Why?
|
| Young Adult | 1 | 2020 | 1855 | 0.110 |
Why?
|
| Chronic Disease | 3 | 2021 | 403 | 0.110 |
Why?
|
| Prognosis | 3 | 2019 | 739 | 0.100 |
Why?
|
| Pandemics | 2 | 2023 | 227 | 0.080 |
Why?
|
| Illinois | 2 | 2020 | 223 | 0.080 |
Why?
|
| United States | 3 | 2019 | 1943 | 0.080 |
Why?
|
| Combined Modality Therapy | 2 | 2019 | 281 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 913 | 0.060 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 31 | 0.050 |
Why?
|
| Nasal Septum | 1 | 2022 | 9 | 0.050 |
Why?
|
| Nasal Lavage | 1 | 2021 | 4 | 0.050 |
Why?
|
| Reading | 1 | 2022 | 35 | 0.050 |
Why?
|
| Mometasone Furoate | 1 | 2021 | 5 | 0.050 |
Why?
|
| Pituitary-Adrenal System | 1 | 2021 | 12 | 0.050 |
Why?
|
| Comprehension | 1 | 2022 | 25 | 0.050 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2021 | 20 | 0.050 |
Why?
|
| Hydrocortisone | 1 | 2021 | 35 | 0.050 |
Why?
|
| Prevalence | 1 | 2023 | 435 | 0.050 |
Why?
|
| Hospitals, Teaching | 1 | 2021 | 29 | 0.050 |
Why?
|
| Logistic Models | 1 | 2022 | 366 | 0.050 |
Why?
|
| Infant | 1 | 2023 | 529 | 0.050 |
Why?
|
| Neck Dissection | 1 | 2020 | 19 | 0.040 |
Why?
|
| Urbanization | 1 | 2020 | 2 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2020 | 53 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2019 | 62 | 0.040 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2019 | 26 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2019 | 80 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 40 | 0.040 |
Why?
|
| Patient Selection | 1 | 2020 | 170 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 329 | 0.040 |
Why?
|
| Paranasal Sinuses | 1 | 2019 | 50 | 0.040 |
Why?
|
| Incidence | 1 | 2018 | 731 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 1689 | 0.030 |
Why?
|